Tekla World Healthcare Fund Fundamentals

THW Fund  USD 10.85  0.05  0.46%   
Fundamental analysis of Tekla World allows traders to better anticipate movements in Tekla World's stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tekla World Healthcare Fund Price To Earning Analysis

Tekla World's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Tekla World Price To Earning

    
  12.08 X  
Most of Tekla World's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla World Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition
Based on the latest financial disclosure, Tekla World Healthcare has a Price To Earning of 12.08 times. This is much higher than that of the Category family and notably higher than that of the Family category. The price to earning for all United States funds is 84.99% lower than that of the firm.

Tekla World Healthcare Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tekla World's current stock value. Our valuation model uses many indicators to compare Tekla World value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tekla World competition to find correlations between indicators driving Tekla World's intrinsic value. More Info.
Tekla World Healthcare is rated below average in price to earning among similar funds. It also is rated below average in beta among similar funds totaling about  0.09  of Beta per Price To Earning. The ratio of Price To Earning to Beta for Tekla World Healthcare is roughly  11.73 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Tekla World by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Tekla Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla World's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the funds which would be a good addition to a portfolio. Peer analysis of Tekla World could also be used in its relative valuation, which is a method of valuing Tekla World by comparing valuation metrics of similar companies.
Tekla World is currently under evaluation in price to earning among similar funds.

Tekla Fundamentals

About Tekla World Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tekla World Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla World using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla World Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Tekla World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by Tekla Capital Management LLC. Tekla World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States. Tekla World operates under Asset Management classification in the United States and is traded on New York Stock Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tekla Fund

Tekla World financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla World security.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators